Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tal Medical’s LFMS device has demonstrated rapid antidepressant effects in clinical studies, with a single 20-minute session showing greater effect than standard antidepressants after several weeks or rTMS after six weeks. The RAPID trial—a double-blind, sham-controlled study—was ongoing to assess durability and optimal dosing. The company was preparing for pivotal trials and commercialization as of the last updates
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tal Medical.